IDEXX Laboratories
Stock Forecast, Prediction & Price Target
IDEXX Laboratories Financial Estimates
IDEXX Laboratories Revenue Estimates
IDEXX Laboratories EBITDA Estimates
IDEXX Laboratories Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $3.21B N/A | $3.36B 4.72% | $3.66B 8.71% | Avg: $4.34B Low: $4.34B High: $4.34B avg. 18.64% | Avg: $4.78B Low: $4.78B High: $4.78B avg. 10.23% | Avg: $5.26B Low: $5.26B High: $5.26B avg. 9.87% | Avg: $5.79B Low: $5.79B High: $5.79B avg. 10.14% |
Net Income
% change YoY
| $744.84M N/A | $679.08M -8.82% | $845.04M 24.43% | Avg: $1.05B Low: $1.05B High: $1.05B avg. 25.30% | Avg: $1.21B Low: $1.21B High: $1.21B avg. 14.31% | Avg: $1.38B Low: $1.38B High: $1.38B avg. 14.42% | Avg: $1.59B Low: $1.59B High: $1.59B avg. 15.13% |
EBITDA
% change YoY
| $932.02M N/A | $898.76M -3.56% | $1.21B 35.48% | Avg: $1.16B Low: $1.16B High: $1.16B avg. -4.20% | Avg: $1.28B Low: $1.28B High: $1.28B avg. 10.23% | Avg: $1.41B Low: $1.41B High: $1.41B avg. 9.87% | Avg: $1.55B Low: $1.55B High: $1.55B avg. 10.14% |
EPS
% change YoY
| $8.74 N/A | $8.12 -7.09% | $10.17 25.24% | Avg: $12.61 Low: $12.61 High: $12.61 avg. 23.98% | Avg: $14.41 Low: $14.41 High: $14.41 avg. 14.31% | Avg: $16.49 Low: $16.49 High: $16.49 avg. 14.42% | Avg: $18.99 Low: $18.99 High: $18.99 avg. 15.13% |
Operating Expenses
% change YoY
| $957.40M N/A | $1.10B 15.47% | $1.09B -1.15% | Avg: $1.12B Low: $1.12B High: $1.12B avg. 3.38% | Avg: $1.24B Low: $1.24B High: $1.24B avg. 10.23% | Avg: $1.36B Low: $1.36B High: $1.36B avg. 9.87% | Avg: $1.50B Low: $1.50B High: $1.50B avg. 10.14% |
FAQ
What is IDEXX Laboratories stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 17.29% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is 1.05B, average is 1.05B and high is 1.05B.
What is IDEXX Laboratories stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 12.22% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is $4.34B, average is $4.34B and high is $4.34B.
What is IDEXX Laboratories stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 16.96% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is $12.61, average is $12.61 and high is $12.60.